Seenu Hariprasad to Clinical Trials as Topic
This is a "connection" page, showing publications Seenu Hariprasad has written about Clinical Trials as Topic.
Connection Strength
0.576
-
Review of ranibizumab trials for neovascular age-related macular degeneration. Semin Ophthalmol. 2011 Nov; 26(6):372-9.
Score: 0.265
-
Abicipar pegol for neovascular age-related macular degeneration. Expert Opin Biol Ther. 2020 09; 20(9):999-1008.
Score: 0.121
-
An Overview of the Fovista and Rinucumab Trials and the Fate of Anti-PDGF Medications. Ophthalmic Surg Lasers Imaging Retina. 2017 02 01; 48(2):100-104.
Score: 0.095
-
Ocriplasmin: nonsurgical option for VMA and macular hole, but with potential barriers to practical use. Ophthalmic Surg Lasers Imaging Retina. 2013 Mar-Apr; 44(2):113-6; discussion p.113.
Score: 0.073
-
Gene Therapy Trial Update: A Primer for Vitreoretinal Specialists. Ophthalmic Surg Lasers Imaging Retina. 2016 Jan; 47(1):6-12.
Score: 0.022